cobaltiprotoporphyrin has been researched along with glycogen in 2 studies
Studies (cobaltiprotoporphyrin) | Trials (cobaltiprotoporphyrin) | Recent Studies (post-2010) (cobaltiprotoporphyrin) | Studies (glycogen) | Trials (glycogen) | Recent Studies (post-2010) (glycogen) |
---|---|---|---|---|---|
283 | 0 | 108 | 25,566 | 576 | 3,794 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jollow, DJ; Spaethe, SM | 1 |
Abraham, NG; Fedorova, L; Hinds, TD; Kappas, A; Kim, DH; Meadows, C; Peterson, SJ; Puri, N; Shapiro, J; Sodhi, K | 1 |
2 other study(ies) available for cobaltiprotoporphyrin and glycogen
Article | Year |
---|---|
Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450.
Topics: Acetaminophen; Animals; Antipyrine; Blood Glucose; Cricetinae; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Glutathione; Glycogen; Male; Mesocricetus; Microsomes, Liver; Mixed Function Oxygenases; Pharmaceutical Preparations; Porphyrins; Protoporphyrins; Rats; Rats, Inbred Strains; Uridine Diphosphate Glucuronic Acid | 1989 |
Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21.
Topics: Adiposity; Animals; Fatty Liver; Fibroblast Growth Factors; Glucose Transporter Type 1; Glycogen; Heme; Heme Oxygenase-1; Leptin; Liver; Male; Membrane Proteins; Mesoporphyrins; Mice; Mice, Obese; Obesity; PPAR alpha; Protoporphyrins; Tin Compounds; Transcription Factors; Weight Gain | 2014 |